Concepedia

James C. Shanks

JC

Statistics

Publications

8

Citations

616

H-Index

8

Active since

1968

Affiliations

Dana-Farber Cancer Institute(Current)

Cedars-Sinai Medical Center

Stanford University

The Ohio State University

The University of Texas MD Anderson Cancer Center

James C. Shanks is an author at Dana-Farber Cancer Institute specializing in speech perception, health sciences, and medicine.

ORCID

Top concepts

Publications per year

1968–2022

8

Publications

8

Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211)

Pamela L. Kunz, Noah Graham, Paul J. Catalano et al. · Journal of Clinical Oncology · 2022 · 268 citations · Full text

A randomized study of temozolomide or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors: A trial of the ECOG-ACRIN Cancer Research Group (E2211).

Pamela L. Kunz, Paul J. Catalano, Halla Nimeiri et al. · Journal of Clinical Oncology · 2018 · 169 citations

, , +17

Vismodegib or cixutumumab in combination with standard chemotherapy for patients with extensive‐stage small cell lung cancer: A trial of the ECOG‐ACRIN Cancer Research Group (E1508)

Chandra P. Belani, Suzanne E. Dahlberg, Charles M. Rudin et al. · Cancer · 2016 · 67 citations

Aqueductal CSF Stroke Volume Is Increased in Patients with Idiopathic Normal Pressure Hydrocephalus and Decreases after Shunt Surgery

James C. Shanks, Karin Markenroth Bloch, Katarina Laurell et al. · American Journal of Neuroradiology · 2019 · 40 citations · Full text

A functional speech impression used to fabricate a maxillary speech prosthesis for a partial glossectomy patient

Jonathan C. Knowles, Varoujan A. Chalian, James C. Shanks · Journal of Prosthetic Dentistry · 1984 · 25 citations

, , +12

1–5 of 8